RST Rehabilitacja
- Address
- lock Available on a paid plan
RST Rehabilitacja - Cardiovascular and Metabolic Research Center
RST Rehabilitacja is a clinical research facility specializing in cardiovascular disease and metabolic disorders. The center focuses on investigating innovative therapeutic approaches for patients with complex comorbidities, particularly those at the intersection of cardiovascular health and metabolic dysfunction.
- Cardiovascular disease management and prevention
- Obesity treatment and metabolic interventions
- Novel pharmacological therapies for cardiometabolic conditions
The center is actively engaged in evaluating cutting-edge treatments that address obesity in patients with established cardiovascular disease, contributing to the development of comprehensive therapeutic strategies. Through participation in international clinical trials, RST Rehabilitacja plays a vital role in advancing evidence-based approaches to managing cardiometabolic health and improving outcomes for high-risk patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in RST Rehabilitacja
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of LY3437943 in Patients with Severe Obesity and Established Cardiovascular Disease: A Randomized, Double-Blind, Phase 3 Trial | Eli Lilly & Co. | Phase III | Not Recruiting | Sep 2023 | Apr 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ly3437943 Sodium | 1 | Unknown | 2023-09-05 | 2023-09-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.